Sjoerd van der Burg

50PUBLICATIONS
194CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Metabolic medicineNanoscale characterisationCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Sep 09, 2026
IL-2 mutein-engrafted antibody MHS552 selectively expands functional regulatory T cells in nonclinical models and healthy participants.

|Aug 13, 2026
Exploring the Immunomodulatory Effects of Fasting-Mimicking Diet in Healthy Individuals: A Pilot Study.

|Jun 08, 2026
Spatial Analysis Reveals Gene Expression and Microenvironmental Changes in the Transition of Nevus to Melanoma.

|Jan 19, 2026
Cell cycle arrest enhances CD8+ T cell effector function by potentiating glucose metabolism and IL-2 signaling.

Floortje J van Haften, Tetje C van der Sluis, Hanna S Hepp

|Nov 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer.

Songul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg

|Jun 11, 2025
Ribociclib-Letrozole Combination as an Alternative for Neoadjuvant Chemotherapy in Selected Postmenopausal Patients with Luminal Breast Cancer (BOOG 2017-01).

Anne F de Groot, Danielle Cohen, Joan B Heijns

Pageof 9

Frequent Collaborators

14 joint publications

Thorbald van Hall

10 joint publications

Els Verdegaal

8 joint publications

Noel F C C de Miranda

7 joint publications

Saskia J Santegoets